News + Blog

Find out what’s happening on campus and across the industry.

Read Fitzsimons Innovation Community news, industry highlights, editorials, and innovation updates happening weekly on our campus.

Filter By:
Sort By:
  • Fitzsimons Innovation Community Member
    • News

    HepQuant Named Rising Star of the Year Finalist by Colorado BioScience Association

    HepQuant, a member of Fitzsimons Innovation Community, has been named a Rising Star of the Year finalist for the Colorado BioScience Association’s 23rd Annual Awards Celebration, recognizing emerging life sciences companies advancing innovation and improving patient care. HepQuant joins fellow finalists Think Bioscience and VitriVax in the category, with winners to be announced at the…
  • 3i logo
    • News

    3i Chooses Fitzsimons Innovation Community for New Headquarters

    Colorado-born microscopy company will bring manufacturing, research and customer demonstration capabilities closer to one of Colorado’s largest concentrations of biomedical researchers AURORA, Colo. – October 21, 2026 – Intelligent Imaging Innovations (3i), a Colorado-based developer and manufacturer of advanced microscopy systems, is relocating its headquarters to Bioscience 3 at Fitzsimons Innovation Community. The move is…
  • Fitzsimons Innovation Community Member
    • News

    Intero Biosystems Wins Startup Battlefield at TechCrunch Disrupt 2026

    Intero Biosystems, a member of Fitzsimons Innovation Community, has been named the winner of Startup Battlefield at TechCrunch Disrupt 2026, earning national recognition for its innovative approach to biotechnology. The achievement highlights Intero’s growing presence in the life sciences industry and brings additional visibility to the innovative companies advancing scientific discovery and commercialization within Colorado’s…
  • Fitzsimons Innovation Community Member
    • News

    Fitzsimons Innovation Community Welcomes Georgia Leadership Delegation

    Fitzsimons Innovation Community recently welcomed 47 business, civic and community leaders from Georgia as part of the Greater North Fulton Chamber of Commerce’s 2026 Strategic Leadership Visit to the Denver metropolitan area. The three-day visit provided opportunities for regional leaders to explore approaches to economic development, transportation, redevelopment and innovation. During their visit to Fitzsimons,…
  • Fitzsimons Innovation Community Member
    • News

    Pathways Bioscience’s PB125 Shows Promising Results in Human Vascular Health Study

    Pathways Bioscience, a member of Fitzsimons Innovation Community, has announced the publication of new clinical research demonstrating that its proprietary botanical formulation, PB125, improved vascular function in older adults and helped preserve vascular function during periods of physical inactivity. The randomized, double-blind, placebo-controlled study, independently conducted by researchers affiliated with the University of Utah, Salt…
  • Fitzsimons Innovation Community Member
    • News

    Children’s Hospital Colorado Recognizes Emerging Pediatric Researchers

    The Colorado Child Health Research Institute at Children’s Hospital Colorado has announced its spring 2026 research award recipients, recognizing early-career investigators advancing innovative approaches to pediatric health challenges. Supported in part by philanthropic investment, the awards provide funding for research addressing conditions including traumatic brain injury, chronic lung disease and other complex pediatric health concerns….
  • Fitzsimons Innovation Community Member
    • News

    CU Anschutz Receives FDA Clearance for CAR T-Cell Cancer Therapy Trial

    The University of Colorado Anschutz has received clearance from the U.S. Food and Drug Administration (FDA) to begin a clinical trial investigating an experimental CAR T-cell therapy for adults with advanced colorectal cancer and pediatric patients with certain solid tumors. Developed by CU Anschutz researchers, the treatment uses genetically modified immune cells designed to target…
  • Fitzsimons Innovation Community Member
    • News

    Fitzsimons Innovation Community Partners With Aurora Public Schools on Student Mural Project

    Fitzsimons Innovation Community is partnering with Aurora Public Schools and NINE dot ARTS to bring a collaborative public art project to its campus during the 2026-27 school year. The initiative will engage 12th-grade students from the Charles Burrell Visual & Performing Arts Campus in creating a mural that reflects Fitzsimons’ mission, values and connection to…
  • Fitzsimons Innovation Community Member
    • News

    Cobio Diagnostics Secures $2.2 Million NIH Grant to Advance Rapid Infection Testing

    Cobio Diagnostics, a member of Fitzsimons Innovation Community, has received a $2.2 million Small Business Innovation Research (SBIR) Fast-Track grant from the National Institutes of Health (NIH) to advance its rapid diagnostic technology for urinary tract infections. The funding will support development of a diagnostic test designed to identify infection-causing bacteria directly from patient samples…
  • Fitzsimons Innovation Community Member
    • News

    CU Anschutz SPARK Colorado Selects Nine Projects Advancing Medical Innovation and Patient Care

    CU Anschutz Innovations has announced nine faculty-led projects selected for the 2026 SPARK Colorado and digiSPARK programs, supporting the development and commercialization of emerging medical technologies. The projects span next-generation cell therapies, artificial intelligence, surgical devices, novel diagnostics and treatments for complex diseases. Since launching in 2018, SPARK Colorado has supported 70 projects, helped launch…
  • Fitzsimons Innovation Community Member
    • News

    Andon Bio Founder Selected for Activate’s 2026 Fellowship Cohort

    Laura White, founder of Andon Bio and a member of Fitzsimons Innovation Community, has been selected for Activate’s 2026 fellowship cohort, joining 50 scientist-innovators working to translate scientific discoveries into commercially viable technologies. Andon Bio is developing a nanopore-based measurement platform designed to improve the predictability of protein production, an essential process in manufacturing biologic…
  • Fitzsimons Innovation Community Member
    • News

    Fitzsimons Board Member Jena Hausmann Recognized Among Nation’s Leading Health Care Executives

    Jena Hausmann, president and CEO of Children’s Hospital Colorado and a member of the Fitzsimons Innovation Community Board of Directors, has been named to Becker’s Hospital Review’s 2026 list of 236 Women Hospital and Health System Presidents and CEOs to Know. The national recognition highlights Hausmann’s leadership of one of the country’s leading pediatric health…